Smead Capital Management 13F holdings, Q3 2013
Holdings as of September 30, 2013 · filings on SEC EDGAR · latest filing →
Smead Capital Management disclosed 29 US equity positions worth $616.6m in its Q3 2013 13F filing. The largest position was Gannett Co Inc Del at 6.7% of the reported book, followed by EBAY and Cabelas Inc. Against the Q2 2013 filing, it opened 1 new position, added to 26 and reduced 1 among the top 29 holdings.
What did Smead Capital Management own in Q3 2013? Top 29 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2013 |
|---|---|---|---|---|---|---|---|
| 1 | Gannett Co Inc Del | 6.7% | $41.5m | 1,550,026 | 19% | added | |
| 2 | EBAY Ebay Inc | Consumer Cyclical | 6.2% | $38.4m | 688,829 | 44% | added |
| 3 | Cabelas Inc | 5.9% | $36.2m | 573,891 | 19% | added | |
| 4 | Walgreen Company | 5.4% | $33.5m | 623,570 | 19% | added | |
| 5 | Amgen Incorporated | 5.0% | $30.8m | 275,448 | 18% | added | |
| 6 | A F L A C Inc | 5.0% | $30.7m | 495,288 | 19% | added | |
| 7 | Bank Of America Corp | 4.7% | $28.8m | 2,089,798 | 19% | added | |
| 8 | DIS Disney Walt Co | Communication Services | 4.6% | $28.3m | 438,586 | 18% | added |
| 9 | JPM Jpmorgan Chase & Co | Financial Services | 4.3% | $26.2m | 507,796 | 19% | added |
| 10 | WFC Wells Fargo & Co New | Financial Services | 4.2% | $26.0m | 630,275 | 19% | added |
| 11 | MRK Merck & Co Inc | Healthcare | 3.6% | $22.4m | 470,912 | 18% | added |
| 12 | Nordstrom Inc | 3.6% | $22.1m | 394,076 | 19% | added | |
| 13 | SBUX Starbucks Corp | Consumer Cyclical | 3.5% | $21.9m | 284,206 | 18% | added |
| 14 | Comcast Cp New Cl A Spl | 3.5% | $21.5m | 497,001 | 19% | added | |
| 15 | Berkshire Hathaway Cl B | 3.4% | $21.2m | 186,770 | 19% | added | |
| 16 | BEN Franklin Resources Inc | Financial Services | 3.4% | $21.1m | 417,516 | 255% | added |
| 17 | PFE Pfizer Incorporated | Healthcare | 3.2% | $19.9m | 693,971 | 19% | added |
| 18 | Block H & R Incorporated | 3.0% | $18.5m | 693,866 | 19% | added | |
| 19 | HD Home Depot Inc | Consumer Cyclical | 3.0% | $18.3m | 241,201 | 19% | added |
| 20 | Accenture Ltd Cl A | 3.0% | $18.2m | 247,644 | 18% | added | |
| 21 | Mylan Laboratories Inc | 2.9% | $17.7m | 462,522 | -13% | reduced | |
| 22 | MDT Medtronic Inc | Healthcare | 2.4% | $14.6m | 274,421 | 19% | added |
| 23 | BMY Bristol-Myers Squibb Co | Healthcare | 2.2% | $13.8m | 298,824 | 19% | added |
| 24 | ABBV Abbvie Inc | Healthcare | 1.9% | $11.7m | 261,957 | 18% | added |
| 25 | JNJ Johnson & Johnson | Healthcare | 1.9% | $11.7m | 134,776 | 19% | added |
| 26 | MCD Mc Donalds Corp | Consumer Cyclical | 1.8% | $11.2m | 116,697 | 19% | added |
| 27 | Abbott Laboratories | 1.4% | $8.7m | 261,986 | 18% | added | |
| 28 | USB U S Bancorp Del New | Financial Services | 0.2% | $1.0m | 27,571 | 0% | held |
| 29 | 1/100 Berkshire Htwy Cla | 0.1% | $340.0k | 200 | – | new |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.